References
- PRISTIQ® (desvenlafaxine) Prescribing Information, Wyeth Pharmaceuticals Inc.
- Data on file, Wyeth Pharmaceuticals Inc.
- Muth EA, Moyer JA, Haskins JT, et al. Biochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine. Drug Dev Res. 1991;23:191-199.
- Troy SM, Dilea C, Martin PT, et al. Bioavailability of once-daily venlafaxine extended release compared with the immediate-release formulation in healthy adult volunteers. Curr Ther Res. 1997;58:492-503.
- Sheehan DV. Sheehan Disability Scale. In: Rush AJ Jr, Pincus HA, First MB, et al., eds. Handbook of Psychiatric Measures, 1st ed. Washington, DC: American Psychiatric Association; 2000:100, 113-115, 526-532.
- Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76:391-396.
- EFFEXOR XR® (venlafaxine HCl) Extended-Release Prescribing Information, Wyeth Pharmaceuticals Inc.
259968-01
